De-escalation of bone-modifying agents in patients with bone metastases from breast cancer: a systematic review and meta-analysis

ConclusionsThese data are supportive of de-escalation of zoledronate from onset for patients with bone metastases from breast cancer.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research